Prevention of Valvular Heart Disease

Valvular heart disease with dark green discoloration of the leaflets: ochronosis

Cardiovascular Surgery ◽

10.1016/s0967-2109(03)00133-9 ◽

2003 ◽

Author(s):

E Erek

Keyword(s):

Heart Disease ◽

Valvular Heart Disease ◽

Dark Green

Download Full-text

Subacute lupus erythematosus, rheumatic valvular heart disease, urinary tract infection

Archives of Dermatology ◽

10.1001/archderm.92.1.112b ◽

1965 ◽

Vol 92 (1) ◽

pp. 112b-113

Author(s):

H. J. Hurley

Keyword(s):

Urinary Tract Infection ◽

Heart Disease ◽

Urinary Tract ◽

Tract Infection ◽

Lupus Erythematosus ◽

Valvular Heart Disease

Download Full-text

P596 Is coronariography mandatory as pre-operative evaluation for valvular heart disease?

European Heart Journal ◽

10.1016/s0195-668x(03)94034-6 ◽

2003 ◽

Vol 24 (5) ◽

pp. 101

Author(s):

R SAMPAIO

Keyword(s):

Heart Disease ◽

Valvular Heart Disease ◽

Operative Evaluation

Download Full-text

Valvular heart disease

Journal of the American College of Cardiology ◽

10.1016/s0735-1097(00)90017-2 ◽

2000 ◽

Vol 35 (5) ◽

pp. 32-34 ◽

Cited By ~ 1

Author(s):

R BONOW

Keyword(s):

Heart Disease ◽

Valvular Heart Disease

Download Full-text

Faculty Opinions recommendation of Valvular heart disease and the use of dopamine agonists for Parkinson's disease.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.1057924.509863 ◽

2007 ◽

Author(s):

Francesco Maisano

Keyword(s):

Parkinson’S Disease ◽

Parkinson's Disease ◽

Heart Disease ◽

Valvular Heart Disease ◽

Dopamine Agonists

Download Full-text

Faculty Opinions recommendation of Valvular heart disease and the use of dopamine agonists for Parkinson's disease.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.1057924.544356 ◽

2007 ◽

Author(s):

John A Paraskos

Keyword(s):

Parkinson’S Disease ◽

Parkinson's Disease ◽

Heart Disease ◽

Valvular Heart Disease ◽

Dopamine Agonists

Download Full-text

Faculty Opinions recommendation of Guidelines on the management of valvular heart disease: The Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.1071694.524606 ◽

2007 ◽

Author(s):

Raimund Erbel

Keyword(s):

Heart Disease ◽

European Society ◽

Valvular Heart Disease ◽

Task Force ◽

European Society Of Cardiology

Download Full-text

Faculty Opinions recommendation of Apixaban in comparison with warfarin in patients with atrial fibrillation and valvular heart disease: findings from the apixaban for reduction in stroke and other thromboembolic events in atrial fibrillation (ARISTOTLE) trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.725585376.793515796 ◽

2016 ◽

Author(s):

Wilbert Aronow

Keyword(s):

Atrial Fibrillation ◽

Heart Disease ◽

Valvular Heart Disease ◽

Thromboembolic Events

Download Full-text

Faculty Opinions recommendation of Cohort profile: prevalence of valvular heart disease in community patients with suspected heart failure in UK.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.727252152.793564310 ◽

2019 ◽

Author(s):

Wendy Tsang

Keyword(s):

Heart Failure ◽

Heart Disease ◽

Valvular Heart Disease ◽

Community Patients

Download Full-text

Faculty Opinions recommendation of Cohort profile: prevalence of valvular heart disease in community patients with suspected heart failure in UK.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.727252152.793528239 ◽

2017 ◽

Author(s):

Juan-Carlos Kaski ◽

Amelia Carro

Keyword(s):

Heart Failure ◽

Heart Disease ◽

Valvular Heart Disease ◽

Community Patients

Download Full-text